Navigation Links
InfraReDx Completes $21 Million Equity Financing
Date:10/12/2010

BURLINGTON, Mass., Oct. 12 /PRNewswire/ -- InfraReDx, Inc., a medical device company developing intelligent cardiovascular diagnostic imaging technologies, today announced the completion of a $21 million equity financing. This round of investment attracted new institutions as well as existing investors, including Sanderling Ventures. Funds from the financing are being used to support the full commercial launch of the LipiScan™ IVUS Coronary Imaging System, the world's first and only intravascular imaging system that combines and co-registers grayscale intravascular ultrasound (IVUS) with InfraReDx's proprietary near infrared (NIR) spectroscopy lipid core plaque (LCP) detection technology.

"We are pleased to provide this novel diagnostic tool for the care of coronary patients. Our existing investors have been very supportive of the effort to develop LipiScan IVUS and the unique capabilities of the system have been instrumental in attracting the support of new investors, as well," said James E. Muller, M.D., founder and chief executive officer of InfraReDx. "The LipiScan IVUS system will enable interventional cardiologists to accurately and rapidly identify the lipid core plaques that complicate stenting and are believed to be the major cause of heart attacks. Our full commercial launch will bring this important and eagerly awaited interventional imaging technology to leading catheterization labs in the U.S. this year. It will be available in Europe in 2011."

The LipiScan IVUS system employs proprietary optical imaging technology to overcome the challenges of heart motion, blood interference, and vascular access to perform NIR spectroscopic analysis of the vessel and produce a chemical map of lipid-core plaque called a Chemogram™. The system provides physicians with a traditional IVUS image that shows plaque location, degree of stenosis and degree of stent expansion. At the same time optical data are
'/>"/>

SOURCE InfraReDx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InfraReDxs New LipiScan™ IVUS Coronary Imaging System to be Highlighted at TCT 2010
2. InfraReDxs LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology
3. InfraReDx to Showcase the LipiScan(TM) Coronary Imaging System at the Cardiovascular Research Foundations (CRF) Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Meeting
4. First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System
5. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
6. Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
7. Apollo Endosurgery Completes First Clinical Case with Newly-Launched FlexShears™ Endoscopic Scissors
8. Randomized Clinical Trial of OrbusNeichs Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment
9. DiFUSION Technologies Completes Successful Antimicrobial Implant Animal Trial
10. IDEV Technologies Completes $46 Million Preferred Stock Financing With Piper Jaffray and Additional Strategic Investor
11. SAFC® Completes Expansion of High-Potency Fermentation Capabilities at Israel Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... WOODLANDS, Texas , April 27, 2015   ... biopharmaceutical company focused on developing breakthrough treatments for human ... on Wednesday, April 29, 2015 after the financial markets ... webcast to discuss clinical development progress and financial results ... Time on April 29, 2015. The dial-in ...
(Date:4/27/2015)...  CryoLife, Inc. (NYSE: CRY ), a leading ... and vascular surgery, announced today that it has received ... Drug Administration ("FDA") verifying that the Company has successfully ... letter it received from the FDA in January 2013. ... March 2015 by the FDA at CryoLife,s manufacturing facility ...
(Date:4/27/2015)... 2015 Numerous Zofran birth defects lawsuits ( ... have highlighted serious concerns surrounding the use of prescription ... the U.S. Centers for Disease Control (CDC), ... have enough information to determine their safety for use ... in the U.S. take at least one medication during ...
Breaking Medicine Technology:Lexicon To Report First Quarter 2015 Financial Results On April 29, 2015 2CryoLife Announces Resolution of FDA Warning Letter 2Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 2Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 3
(Date:4/27/2015)... MD (PRWEB) April 27, 2015 Jesse ... the 2015–2020 United States Pharmacopeial Convention (USP) at the ... is Professor of Medicine at Georgetown University and the ... and Stewardship (COMPASS). , As USP President, a volunteer ... Convention Meeting. He will be a voting member, ex ...
(Date:4/27/2015)... MN (PRWEB) April 27, 2015 Based ... Secura Consultants is one of the few insurance marketing ... in the income and asset protection markets as well ... the industry has afforded Secura Consultants the opportunity to ... to make doing business easier and quicker. , An ...
(Date:4/27/2015)... 27, 2015 Array Health , ... has announced that Lance Hood, senior director of marketing, ... annual Direct-to-Consumer Health Care Marketing Summit on ... Smith, Partner and Director of Payer Services, Leavitt Partners, ... consumerism – through a retail/e-commerce perspective – and equip ...
(Date:4/27/2015)... Thanks to a $7.5 million grant from the ... including American University, will operate in a new center ... research aimed at ending the AIDS epidemic. , Nearly ... or AIDS, according to the latest statistics. At the ... the age of 13 was living with HIV, well ...
(Date:4/27/2015)... Sitting or standing for long periods of time ... for those whose occupation requires them to be sitting while ... or to be on their feet for most of the ... more severe and longer lasting. These people suffer from a ... of Northeast Houston Vein Center is offering tips on how ...
Breaking Medicine News(10 mins):Health News:Dr. Jesse Goodman Elected President of the USP Convention 2Health News:Simplified Solutions Now Makes Disability Insurance Business With Secura Consultants Even Easier! 2Health News:Array Health’s Senior Director of Marketing to Present at The Fourth Annual Direct-to-Consumer Health Care Marketing Summit 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 2Health News:D.C. Center for AIDS Research Established with New Grant from NIH 3Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3
... the latest medicine kings in the treatment of many complex ... in the June issue of Angiology if pine bark extract ... of muscles. ,The reason and scientific basis behind ... to the muscles which speeds recovery after physical exercise. ...
... the chikungunya disease all over the country and in Tamil ... Director, Vector borne Diseases, Tamil Nadu, said today. ... ,Preventive measures are on to restrict the ... a seminar on sensitization programme for medical staff and students ...
... red wines have a sleep inducing ingredient, melatonin. That’s probably the ... hormone is produced by the pineal gland in the brain, which ... hit the sack! , ,The discovery of melatonin in ... bottle in the evening to wind down after a day's hard ...
... receptor activity in the postmortem brain tissue from patients ... of Medicine, in collaboration with scientists at the City ... in its function. A high level of erbB4 receptor ... the receptors in the prefrontal cortex of schizophrenic patient ...
... of subjecting drug addicts to shock therapy as a means ... controversies. Now, the Scottish Executive is doing more research into ... labeled as Neuro-Electric Therapy (NET) is executed with the use ... pulses are sent into the brain. This is known to ...
... center, a tuberculosis case alerts the health authorities //. ... worker, who works at the Centenary Childcare and Early ... ,Dr Michael Whitby, a spokesman of Australian Medical ... the center are at risk of getting infected. ...
Cached Medicine News:Health News:A herbal delight for athletes in solving cramp and pain problems 2Health News:A herbal delight for athletes in solving cramp and pain problems 3Health News:Schizophrenia Complicates With Altered Receptor Activity 2Health News:Schizophrenia Complicates With Altered Receptor Activity 3
IFA for the direct detection of Respiratory Syncytial Virus (RSV)...
... RSV Test utilizes a new, improved format that ... rapid RSV detection. The testing device employs innovative ... reagents have already been applied to the testing ... with clear-cut results shown by the appearance of ...
Latex agglutination slide test for the qualitative detection of rotavirus from fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: